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ABSTRACT
Introduction: In order to manage skin condi-
tions at a national referral hospital level in
Kenya, specialized dermatology services, such as
dermatologic surgery, dermatopathology, pho-
totherapy, and sub-specialty care, should be
offered, as is typically available in referral hos-
pitals around the world. A Kenyan patient with
prurigo nodularis, whose severe itch remitted
after phototherapy treatment at the University
of California, San Francisco (UCSF), inspired the
development of a phototherapy service at Aca-
demic Model Providing Access to Healthcare
(AMPATH), a partnership in Western Kenya
between Moi Teaching and Referral Hospital,
Moi University College of Health Sciences, and
a consortium of North American academic
medical centers.
Methods: Initial project funds were raised
through a crowdfunding campaign and
fundraising events. A new narrowband ultravi-
olet B phototherapy unit and replacement bulbs
were donated and air shipped to Eldoret, Kenya.
A team of dermatologists and phototherapy
nurses from UCSF conducted a 2-day training
session. US-based dermatologists affiliated with
Karen Ly and Aileen Y. Chang contributed equally as co-
first authors.
Toby Maurer and Wilson Liao contributed equally as co-
last authors.
Enhanced Digital Features To view enhanced digital
features for this article go to https://doi.org/10.6084/
m9.figshare.10075427.
K. Ly  A. Y. Chang (&)  M. Jose  M. P. Smith 
K. Beck  S. Sekhon  I. Muraguri  S. J. Coates 
Q. Thibodeaux  S. Hulse  M. Gualberto  C. Jeon 
M. Nakamura  T. Bhutani  W. Liao
Department of Dermatology, University of
California, San Francisco, CA, USA
e-mail: aileen.chang@ucsf.edu
A. Y. Chang  S. K. Kiprono  S. J. Coates  T. Maurer
Academic Model Providing Access to Healthcare,
Eldoret, Kenya
S. K. Kiprono
Department of Medicine, Moi University School of
Medicine, Eldoret, Kenya
M. Mungai
Moi Teaching and Referral Hospital, Eldoret, Kenya
C. Jeon
Division of Dermatology, Harbor-UCLA Medical
Center, Torrance, CA, USA
M. Nakamura
Department of Dermatology, University of
Michigan, Ann Arbor, MI, USA
T. Maurer
Department of Dermatology, Indiana University,
Indianapolis, IN, USA
Dermatol Ther (Heidelb) (2020) 10:107–117
https://doi.org/10.1007/s13555-019-00342-1
AMPATH provide ongoing support through
regular communication and on-site visits.
Results: Early in implementation, challenges
faced included training clinical staff with lim-
ited experience in phototherapy and improving
communication between nurses and clinicians.
More recent challenges include frequent rota-
tion of specialty clinic nurses in the dermatol-
ogy clinic, adaptation of phototherapy
guidelines to balance patient volume with ser-
vice delivery capacity, and training assessment
of disease activity in darkly pigmented skin.
Conclusion: Strategies that have been helpful
in addressing implementation challenges
include: increasing on-site and remote training
opportunities for clinicians and nurses, devel-
oping a tiered payment schema, educating
patients to combat misconceptions about pho-
totherapy, dynamic phototherapy referral
guidelines to accommodate service delivery
capacity, and prioritizing the engagement of a
multidisciplinary team.
Keywords: Africa; Dermatology; Kenya; Low-
and middle-income countries; Phototherapy;
Resource-limited settings; Ultraviolet light; UVB
Key Summary Points
In order to manage skin conditions at a
national referral hospital level in Kenya,
specialized dermatology services, such as
phototherapy, should be offered, as are
routinely available at referral hospitals
around the world.
A Kenyan patient with
intractable pruritus, whose symptoms
remitted after phototherapy treatment at
the University of California, San Francisco
(UCSF), inspired the development of a
phototherapy service at Academic Model
Providing Access to Healthcare
(AMPATH), a partnership in Western
Kenya between Moi Teaching and Referral
Hospital, Moi University College of
Health Sciences, and a consortium of
North American academic medical
centers.
Implementation challenges faced included
training of clinical staff with limited
experience in phototherapy, developing
phototherapy as a sustainable service,
educating patients, adapting
phototherapy guidelines to a local
context, and multidisciplinary
collaboration.
Strategies that have been helpful include
increasing training opportunities,
developing a tiered payment schema,
educating patients, maintaining dynamic
phototherapy guidelines, and prioritizing
the engagement of a multidisciplinary
team.
INTRODUCTION
In order to manage skin conditions at a national
referral hospital level, specialized dermatology
services such as dermatologic surgery, der-
matopathology, phototherapy, and sub-spe-
cialty care, should be offered, as are routinely
available at referral hospitals around the world.
While visiting family near San Francisco, Cali-
fornia, a Kenyan patient with Fitzpatrick skin
type 6 presented for evaluation to the Univer-
sity of California, San Francisco (UCSF) Psoriasis
and Skin Treatment Center. This patient had
been suffering from intractable pruritus for
1 year despite seeking care from providers in
Kenya and the United States. At UCSF, the
patient was successfully treated with narrow-
band ultraviolet B (nbUVB) phototherapy for
severe pruritus from prurigo nodularis. This
patient’s subsequent motivation to improve the
treatment of skin diseases in Kenya inspired the
development of an ultraviolet phototherapy
service in Western Kenya, where UCSF derma-
tologists had been helping to develop derma-
tology capacity through AMPATH (Academic
Model Providing Access to Healthcare) for
10 years.
Since 2001, AMPATH has been a partnership
between Moi Teaching and Referral Hospital
(MTRH), Moi University College of Health
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Sciences (MUCHS), and a consortium of North
American academic medical centers. AMPATH,
a President’s Emergency Plan for AIDS Relief—
United States Agency for International Devel-
opment supported implementing partner, col-
laborates with the Ministry of Health to serve a
catchment area of over 4 million people and has
supported HIV care delivery for over 150,000
patients at over 500 sites across Western Kenya.
Using the infrastructure and healthcare delivery
model created through HIV care, AMPATH has
been providing care for other chronic diseases,
including dermatologic conditions.
MTRH, one of Kenya’s two national referral
hospitals, serves approximately 24 million peo-
ple from Western Kenya and neighboring
countries. The MTRH campus provides both
inpatient and outpatient services, with several
specialty care buildings including the AMPATH
Centre (HIV care), Chandaria Centre for Cancer
and Chronic Diseases, Riley Mother Baby
Hospital, Shoe4Africa Children’s Hospital,
Rafiki Center for Excellence in Adolescent
Health, and Majaliwa Surgical Center. There are
two dermatology consultants (attendings) and
two dermatology clinical officers (mid-level
providers who have completed additional der-
matology training) providing care at MTRH.
The dermatology clinic is part of the specialty
clinics. Nurses assigned to the specialty clinics
rotate among dermatology, cardiology, dia-
betes, neurology, and mental health clinics.
Through MUCHS, a Masters in Medicine
(MMed) of Dermatology program is anticipated
to enroll its first class in September 2020 and
will be the first MMed of Dermatology program
in Kenya. Dermatology registrars (residents) will
complete the clinical training component of
their MMed program at MTRH.
As called for by the Government of Kenya,
the provision of affordable, equitable, and
accessible care that is responsive to population
needs includes providing care for skin condi-
tions. This is considered an essential health
service that should be offered across the
healthcare system, from primary care facilities
to national hospitals [1]. Kenya is a lower mid-
dle-income country with a population of 51.4
million, of which 36.8% live on less than $1.90
per day [2]. The life expectancy is 67.3 years,
mortality rate in children under age five is 46
per 1000 live births, and the nationwide
prevalence of HIV is 4.8% of the population
ages 15–49 years old [2]. The prevalence of skin
disorders in Kenya has been estimated to be
29.6–50.9% [3–5]. Common skin conditions
include tinea versicolor, tinea capitis, scabies,
atopic dermatitis, psoriasis, vitiligo, acne vul-
garis, and dermatitis [5, 6]. The National
Hospital Insurance Fund (NHIF) is the main
health insurer, covering 16% of Kenyans [7].
NHIF contribution is mandatory for formal
sector workers and voluntary for informal sector
workers. Although informal sector workers form
83.4% of total employed individuals in Kenya
[8], they accounted for only 24% of the total
number of individuals enrolled in the NHIF in
2017 [9]. At MTRH, the vast majority of patients
work in the informal sector, do not contribute
to NHIF, and pay for healthcare expenses out-
of-pocket.
In the public healthcare system of Kenya,
there is limited access to specialty care, unreli-
able supply of medications and medical sup-
plies, and suboptimal health system
infrastructure. At primary care and county
facilities, clinical officers and nurses are often
called upon to provide dermatologic care,
though many have limited training in the
diagnosis and treatment of skin diseases [10].
The availability of dermatologic therapies varies
based on healthcare facility level and facility
supply. Phototherapy and biologic therapies are
not readily available. The rationale for devel-
oping an ultraviolet phototherapy service was
that it would enhance the specialized derma-
tology care being provided at MTRH and sup-
port the clinical training of MUCHS
dermatology registrars who represent the future
local dermatology consultant workforce. In this
manuscript, we will discuss the challenges and
lessons learned thus far from the development
and implementation of the ultraviolet pho-
totherapy service at MTRH.
METHODS
Multiple fundraising events and a crowdfund-
ing campaign were used to fund the initial costs
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of this project. A fundraising website described
the inspiration and mission of our project: raise
funds for a state-of-the-art phototherapy unit
for MTRH; enhance MTRH as the clinical
training site for MUCHS dermatology registrars;
and build capacity to deliver dermatologic care
to Kenyans. A video was created telling the story
of our Kenyan patient and this patient’s desire
to bring phototherapy to Kenya. The website
and video were circulated within the UCSF
community, via email, text, and social media,
to raise support and increase interest. We also
partnered with a local establishment in San
Francisco to host a fundraising event, with
admission fees and a portion of proceeds going
toward our campaign.
Ultimately, National Biological Corporation
(Beachwood, Ohio, USA) donated a new nbUVB
cabinet phototherapy unit (model FOLDALITE
32, Fig. 1). nbUVB was chosen, rather than
broadband UVB or UVA, due to its safety profile
[11–14] and efficacy in a range of dermatologic
conditions. Approvals and import permits were
obtained after 6 months of close communica-
tion between UCSF dermatologists, National
Biological Corporation, and MTRH executive
leadership. The phototherapy machine and
bulbs, including replacement bulbs, were ship-
ped by air from the United States to Nairobi,
Kenya and then onward to Eldoret, Kenya. Dur-
ing this 6-month period, a suitable room within
MTRHwas identified and approved to be used for
phototherapy. Modifications to the room were
made including fan installation, window tint-
ing, and securing of doors and windows.
Machine installation was performed by the
MTRH Department of Medical Engineering.
After installation of the phototherapy
machine, a team of UCSF dermatologists and
phototherapy nurses traveled to Kenya to con-
duct a 2-day initial training session for the
specialty clinic nurses, dermatology clinical
officers, and dermatologists. This training cov-
ered diseases treated with phototherapy, dose
administration, shielding, machine calibration,
documentation, and the assessment of side
Fig. 1 Narrowband ultraviolet B cabinet phototherapy unit
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effects and treatment response. Instruction was
provided in the form of lectures and hands-on
training with the phototherapy machine. The
UCSF team has provided ongoing support
through regular communication via conference
calls and electronic mail. Additionally, US-
based dermatologists affiliated with AMPATH
make regular visits to Kenya to support the
implementation process. Machine calibration is
performed weekly by phototherapy nurses, and
the MTRH Department of Medical Engineering
performs regular machine maintenance.
Since treatment of patients began, constant
feedback has been elicited from nurses and
clinicians involved with the provision of pho-
totherapy. This feedback will be discussed in the
Results section. This article does not contain
any studies with human participants or animals
performed by any of the authors.
RESULTS
Between February 2018 and August 2019, 62
patients received phototherapy treatment at
MTRH for a range of skin conditions, including
psoriasis, atopic dermatitis, cutaneous T-cell
lymphoma, and vitiligo. Early on in implemen-
tation, the challenges faced by nurses included
learning a new advanced skill set as none were
familiar with phototherapy prior to training,
developing a documentation system for tracking
patients and their progress, and effectively
communicating their concerns with the derma-
tology clinical officers and consultants. Chal-
lenges faced by dermatology clinical officers and
consultants included becoming familiar with the
clinical indications for phototherapy, under-
standing risks, benefits, and alternatives to
phototherapy, and recognizing side effects from
phototherapy. More recent challenges include
frequent rotation of specialty clinic nurses in the
dermatology clinic and adaptation of pho-
totherapy guidelines to the local context such
that patient volume is balanced with the capac-
ity of the phototherapy service. Another ongo-
ing challenge has been lack of large-volume
topical corticosteroids, which are often used as
adjuvant therapy in most conditions treated
with ultraviolet therapy.
DISCUSSION
The first ultraviolet phototherapy service in
Western Kenya has been developed and imple-
mentation is ongoing. The challenges we have
encountered are related to the introduction of a
relatively unfamiliar therapy and provision of
this service to a patient population that pre-
dominantly pays for healthcare expenses
entirely out-of-pocket. Herein, we will discuss
our challenges, lessons learned, and future
directions (Table 1).
One of the biggest challenges has been train-
ing a clinical team composed of nurses, derma-
tology clinical officers, and dermatology
consultants with limited to no prior experience
administering phototherapy. Education was
initially provided through a 2-day orientation
session, which included lectures, practical exer-
cises, and clinical case studies. Based on feedback
from the clinical team, additional opportunities
for training were identified as necessary to opti-
mize and standardize care. To address this need,
we introduced on-site refresher training sessions
led by UCSF personnel with certification in
phototherapy administration. During these ses-
sions, important concepts are reviewed and
reinforced through presentations and practical
demonstrations. During regularly scheduled
video conference calls with the UCSF team,
clinicians and nurses can discuss challenging
clinical cases. Furthermore, it became apparent
that the frequent rotation of specialty clinic
nurses among the various specialty clinics was a
barrier to phototherapy implementation. Some
nurses had not attended the initial training ses-
sion; some were more interested in photother-
apy than others and thus more receptive to
training than others. To address this, MTRH
nursing leadership assigned three specialty clinic
nurses, each of whom had shown interest in
phototherapy, to the dermatology clinic. Having
the same dermatology nurses has allowed us to
focus training efforts on personnel who will be
consistently posted to the dermatology clinic,
which has facilitated efficient phototherapy
knowledge and skills acquisition and optimized
the safety, efficacy, and standards of photother-
apy service delivery.
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Another challenge was addressing financial
considerations related to balancing affordability
of accessing phototherapy with its sustainability
as a clinical service. Phototherapy typically
requires multiple sessions per week for at least
2–3 months. In addition to treatment cost,
Table 1 Establishment of a phototherapy service in Eldoret, Kenya—key challenges, solutions, and future directions
Key Challenges Solutions Implemented
Provider education
Training a clinical team with limited
phototherapy knowledge and experience
Two-day orientation session for specialty clinic nurses, dermatology clinical
officers, and dermatologists
On-site refresher training sessions
Regularly scheduled video conference calls
One of three specialty clinic nurses with training and interest in
phototherapy is always assigned to dermatology clinic
Posters in clinic with referral and dosing guidelines
Financial considerations
Balancing affordability with clinic sustainability
Negotiation with the National Hospital Insurance Fund to include
phototherapy as a covered service
Tiered payment schema
Profit allocated to the hospital’s dermatology department
Patient education
Misconceptions about phototherapy
Patient orientation session and take-home educational pamphlets
Nurses reinforce phototherapy education at every visit
Clinical care
Adapting phototherapy referral and treatment
guidelines to local context
Dynamic phototherapy referral guidelines: strict early in implementation to
limit referrals while the service was developing and later modified with
increased service delivery capacity
Utilize dosing guidelines used by University of California, San Francisco
(UCSF) collaborators and anticipate these may be adjusted with
increased local experience
Multidisciplinary collaboration
Engagement of multidisciplinary stakeholders
Development of a new professional and cultural norm between clinicians
and nurses through open communication, regular meetings, frequent
solicitation of feedback
Discussion with hospital administrators to determine payment structure,
clinic space allotment, staff allocation, and equipment security
Partnership with hospital pharmacists to develop compounding of topical
corticosteroids
Future directions
Develop training tools for assessment of disease activity in darkly pigmented skin
Conduct observational studies to evaluate patient outcomes for a range of skin diseases
Assess patient acceptability of phototherapy
Evaluate the phototherapy service’s financial model
Engage in opportunities to collaborate with other phototherapy services in Africa
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travel cost and travel time can be significant
barriers to accessing care as these are associated
with lost income. Patients travel approximately
1–2 h to reach the clinic, and some come from
Nairobi, which is at least 6 h away by road in a
private vehicle and longer by public trans-
portation. When determining the suitability of
a phototherapy referral, the clinician considers
the clinical appropriateness (e.g., diagnosis,
prior treatments failed, degree of body surface
area involvement, contraindications) and all
patient costs related to phototherapy, including
the cost per session, cost of travel, and antici-
pated number of sessions. These aspects of
phototherapy are discussed with patients before
this treatment modality is initiated.
In order to develop phototherapy as a sus-
tainable clinical service, establishing a revenue
stream that balances financial viability with
patient affordability was a high priority from
the beginning. We worked with the NHIF to
include phototherapy cost for those with NHIF
insurance. Approximately 10% of our pho-
totherapy patients have NHIF insurance. Ini-
tially, the main challenge with the use of NHIF
was obtaining approval before every pho-
totherapy session. We negotiated with NHIF to
provide phototherapy as a package of eight
sessions. For individuals without NHIF cover-
age, which accounts for the vast majority of
patients, a reduced fee is offered. For those
individuals with limited to no ability to pay, a
social worker is engaged to assess the need for a
payment plan and consider waiver of treatment
costs. Transportation costs continue to be a
barrier. On various occasions, staff have used
personal funds to assist patients. Of note, the
cost of the FOLDALITE 32 nbUVB machine
was 13,900 USD, replacement bulbs were 3400
USD, and a UVB-500C metering device and
stand was 780 USD. The nbUVB unit was
donated, while the replacement bulbs, metering
device and stand were purchased using the ini-
tial funds raised. With regard to sustainability,
the phototherapy service has become a core
service provided by the hospital. All profit gen-
erated from the phototherapy service is directed
towards supporting the MTRH dermatology
department. With a forward-looking financial
plan, the donation of the phototherapy
machine has helped build dermatology capacity
in a sustainable manner and supports the pa-
tient care, teaching, and research mission of
AMPATH Dermatology.
As ultraviolet phototherapy is a new and
unfamiliar technology to many Kenyans, mis-
conceptions have posed a significant challenge.
Misconceptions include the belief that nbUVB
phototherapy is identical to the form of radia-
tion therapy used to treat cancer (e.g., X-ray
therapy), greatly increases the risk of skin can-
cer, or that skin improvement equates to a cure.
Misconceptions manifest in patients’ reluctance
to initiate treatment or a failure to return to
clinic once improvement is achieved, often
times leading to disease recurrence. To combat
misconceptions, patients are educated on
expectations regarding treatment duration,
treatment outcomes, and potential side effects
through an orientation session and take-home
educational pamphlets. Nurses reinforce
important points at every visit and have been
instrumental in addressing misconceptions.
Challenges related to clinical care are ongo-
ing as implementation progresses. At the
beginning of implementation, we used strict
phototherapy referral guidelines that required
large body surface area involvement or failure of
topical and systemic medications to avoid a
large number of referrals while we had a new
service with clinicians and nurses lacking
hands-on phototherapy experience. After the
aforementioned challenges related to training,
nurse staffing, and NHIF reimbursement were
addressed over the first one and a half years of
implementation, phototherapy referral guideli-
nes were modified to allow for patients with a
lower body surface area involvement and with-
out a systemic medication trial. As the derma-
tology clinic’s patient volume grows and the
number of dermatology providers increases
with the MMed program, we will continue to
use dynamic phototherapy referral guidelines to
maintain service delivery standards, safety, and
efficacy. For determining the starting dose and
dosing schedule, we have used the clinical
experience at the UCSF Psoriasis and
Skin Treatment Center to guide our approach
(Fig. 2). We anticipate that these working
guidelines will be adjusted as we gain more
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experience using phototherapy at MTRH.
Another challenge has been training nurses in
the assessment of disease activity in inflamma-
tory skin conditions, particularly when
erythema can be challenging to appreciate in
darkly pigmented skin. While dermatologists
with experience treating skin conditions in
darkly pigmented patients anecdotally report
Fig. 2 Narrowband ultraviolet B dosing guidelines utilized at Moi Teaching and Referral Hospital (separate file)
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that they rely on other signs of inflammation
(e.g., scale, induration) and patient-reported
symptoms (e.g., itch, pain), we have not iden-
tified published guidelines or training tools for
assessment of disease activity in darkly pig-
mented skin.
Implementation of the phototherapy service
has required the support of a multidisciplinary
team, comprised of clinicians, nurses, pharma-
cists, and hospital administrators. The engage-
ment of these multidisciplinary stakeholders
has been crucial since project inception. Due to
specialized training and an advanced skill set,
clinicians play a fundamental leadership role in
multi-disciplinary teams and must be able to
work closely with nurses, amongst other
healthcare professionals. While clinicians make
referrals to phototherapy, phototherapy
administration is nursing-led, meaning nurses
are the ones who assess patients at each pho-
totherapy session, manage side effects, decide
on dosing for the session, determine which
areas to shield, and ensure infection prevention
and control measures are implemented. Clini-
cians review patients periodically but not at
every phototherapy session. Ultimately, nurses
must be empowered, supported, and invested in
excelling at phototherapy administration. We
have initiated several strategies to try to estab-
lish a new professional and cultural norm in the
phototherapy clinic: regular clinical and
administrative meetings attended by both clin-
icians and nurses, close communication with
hospital nursing leadership, and regular solici-
tation of feedback from nurses and clinicians.
Another essential stakeholder is hospital
administration. Implementation of any clinical
service, particularly a novel one, requires close
partnership with hospital administrators to
negotiate issues around service payment struc-
ture, clinic space allotment, staff allocation, and
security/safeguarding of equipment and sup-
plies. We have also engaged with hospital
pharmacists to try to develop compounding of
topical corticosteroids in order to increase the
availability of 500-g jars, as only 15- to 30-g
tubes are commercially available. Specifically
related to phototherapy, topical corticosteroids
are used as adjuvant therapy and to treat side
effects. With the availability of 500-g jars of
topical corticosteroids, we anticipate that fewer
patients may need phototherapy services.
To date, dermatology capacity development
work at AMPATH has occurred at the national
referral hospital level because in order to provide
affordable, equitable, and accessible dermato-
logic care, there must be specialized dermatol-
ogy services and an adequate number of
dermatology consultants working in the public
healthcare system.With the development of the
MMed of Dermatology at MUCHS and the
phototherapy service at MTRH, progress is being
made towards increasing dermatology capacity
at the referral level. More recently, we have
started to develop a strategy to address derma-
tology capacity at the primary care, sub-county,
and county facilities. We have initiated derma-
tology continuing medical education sessions
for clinicians and nurses at sub-county and
county facilities within the MTRH catchment
area. We also plan to pilot a teledermatology
program to increase access to dermatologic care.
Finally, we have started developing a commu-
nity-based outreach program that aims to sen-
sitize communities within the catchment area of
MTRH that dermatologic conditions can be
treated with a variety of therapies, some of
which are available at primary care and county
facilities and others at the national referral level.
Future directions for the phototherapy ser-
vice are numerous. We plan to evaluate the
phototherapy service, specifically conducting
observational studies to evaluate patient out-
comes for a range of skin diseases, assess patient
acceptability of phototherapy, and evaluate the
financial model. We plan to develop training
tools for assessment of disease activity in darkly
pigmented skin. Phototherapy services exist in
other African countries; however, we have not
been able to find publications from these ser-
vices describing their experience or reporting
clinical outcomes. We are seeking opportunities
to learn from, and collaborate with, other pho-
totherapy services in Africa.
CONCLUSIONS
In conclusion, there have been multiple chal-
lenges in the implementation of an ultraviolet
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phototherapy service at a national referral hos-
pital in Western Kenya. Strategies that have
been helpful in addressing implementation
challenges include: increasing on-site and
remote training opportunities for clinicians and
nurses, developing a tiered payment schema,
educating patients to combat misconceptions
about phototherapy, dynamic phototherapy
referral guidelines to accommodate service
delivery capacity, and prioritizing the engage-
ment of a multidisciplinary team. Future work
includes developing training tools for assess-
ment of disease activity in darkly pigmented
skin, conducting observational studies to eval-
uate patient outcomes, assessing patient
acceptability of phototherapy, evaluating the
financial model of the service, and improving
dermatology care across the public healthcare
system in Western Kenya.
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